John Day

2.0k total citations · 1 hit paper
31 papers, 1.2k citations indexed

About

John Day is a scholar working on Pulmonary and Respiratory Medicine, Virology and Cancer Research. According to data from OpenAlex, John Day has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 7 papers in Virology and 5 papers in Cancer Research. Recurrent topics in John Day's work include Prostate Cancer Treatment and Research (11 papers), HIV Research and Treatment (7 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). John Day is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), HIV Research and Treatment (7 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). John Day collaborates with scholars based in United States, Germany and Sweden. John Day's co-authors include Jack Groskopf, Harry G. Rittenhouse, John Guatelli, Amy Blase, Seongjoon Koo, William J. Ellis, Ina L. Deras, Leonard S. Marks, Yves Fradet and Alan W. Partin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Virology and The Journal of Urology.

In The Last Decade

John Day

28 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment

2015 271 citations Scott A. Tomlins, John Day et al. European Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John Day United States	15	727	355	302	181	94	31	1.2k
Silvia Behnke Switzerland	17	234 0.3×	508 1.4×	160 0.5×	108 0.6×	364 3.9×	24	1.2k
Peter Barry United Kingdom	18	255 0.4×	242 0.7×	349 1.2×	44 0.2×	56 0.6×	59	1.1k
Amy Ly United States	16	182 0.3×	291 0.8×	211 0.7×	294 1.6×	225 2.4×	63	1.1k
Hélène Goulaouic France	15	199 0.3×	799 2.3×	113 0.4×	214 1.2×	249 2.6×	28	1.5k
Marbin Pineda United States	22	328 0.5×	965 2.7×	445 1.5×	32 0.2×	145 1.5×	31	1.7k
Anna Zhou United States	9	182 0.3×	378 1.1×	42 0.1×	71 0.4×	248 2.6×	26	873
Jeffrey M. Gerold United States	8	133 0.2×	320 0.9×	398 1.3×	243 1.3×	215 2.3×	9	989
Collin M. Blakely United States	21	772 1.1×	800 2.3×	406 1.3×	35 0.2×	302 3.2×	75	2.1k
P. A. Bunn United States	14	548 0.8×	378 1.1×	163 0.5×	125 0.7×	486 5.2×	39	1.6k
Jonas J. Heymann United States	15	289 0.4×	171 0.5×	170 0.6×	306 1.7×	169 1.8×	47	1.1k

Countries citing papers authored by John Day

Since Specialization

Citations

This map shows the geographic impact of John Day's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Day with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Day more than expected).

Fields of papers citing papers by John Day

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Day. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Day. The network helps show where John Day may publish in the future.

Co-authorship network of co-authors of John Day

This figure shows the co-authorship network connecting the top 25 collaborators of John Day. A scholar is included among the top collaborators of John Day based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Day. John Day is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Qiu, Ping, Jared Lunceford, Răzvan Cristescu, et al.. (2024). Concordance between an FDA-approved companion diagnostic and an alternative assay kit for assessing homologous recombination deficiency in ovarian cancer. Gynecologic Oncology. 184. 67–73. 6 indexed citations

Day, John. (2017). CCD Camera Detection of HIV Infection. Methods in molecular biology. 1571. 371–387.

Tomlins, Scott A., John Day, Robert J. Lonigro, et al.. (2015). Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment. European Urology. 70(1). 45–53. 271 indexed citations breakdown →

Svensson, Maria A., Sven Perner, John Day, et al.. (2014). A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. Applied immunohistochemistry & molecular morphology. 22(2). 136–141. 15 indexed citations

Dhani, Neesha C., Urban Emmenegger, Jan Jongstra, et al.. (2012). Phase II study of cytarabine in men with docetaxel‐refractory, castration‐resistant prostate cancer with evaluation of TMPRSS2‐ERG and SPINK1 as serum biomarkers. British Journal of Urology. 110(6). 840–845. 7 indexed citations

Day, John. (2010). Of Mice and Media.. The English Journal. 100(1). 70–75. 4 indexed citations

Clark, Susan E., et al.. (2010). Accessible Public Transportation in the United States: Twenty Years After Passage of the ADA. 1 indexed citations

Day, John, Matthias Jost, Mark A. Reynolds, Jack Groskopf, & Harry G. Rittenhouse. (2010). PCA3: From basic molecular science to the clinical lab. Cancer Letters. 301(1). 1–6. 63 indexed citations

Jost, Matthias, John Day, Theodore D. Koreckij, et al.. (2010). Molecular assays for the detection of prostate tumor derived nucleic acids in peripheral blood. Molecular Cancer. 9(1). 174–174. 16 indexed citations

10.

Mehta, Sanjay R., Roberto Badaró, Celsa A. Spina, et al.. (2010). Flow cytometric screening for anti-leishmanials in a human macrophage cell line. Experimental Parasitology. 126(4). 617–620. 14 indexed citations

11.

Deras, Ina L., Sheila M. J. Aubin, Amy Blase, et al.. (2008). PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome. The Journal of Urology. 179(4). 1587–1592. 343 indexed citations

12.

Day, John, Laura E. Martínez, Roman Šášik, et al.. (2006). A computer-based, image-analysis method to quantify HIV-1 infection in a single-cycle infectious center assay. Journal of Virological Methods. 137(1). 125–133. 20 indexed citations

13.

Day, John, et al.. (2006). The effect of the membrane-proximal tyrosine-based sorting signal of HIV-1 gp41 on viral infectivity depends on sequences within gp120. Virology. 354(2). 316–327. 10 indexed citations

14.

Day, John, et al.. (2005). Leucine-Specific, Functional Interactions between Human Immunodeficiency Virus Type 1 Nef and Adaptor Protein Complexes. Journal of Virology. 79(4). 2066–2078. 33 indexed citations

15.

Madrid, Ricardo, Katy Janvier, John Day, et al.. (2004). Nef-induced Alteration of the Early/Recycling Endosomal Compartment Correlates with Enhancement of HIV-1 Infectivity. Journal of Biological Chemistry. 280(6). 5032–5044. 93 indexed citations

16.

Day, John, et al.. (2001). The HIV-1 Nef protein as a target for antiretroviral therapy. PubMed. 5(1). 1–22. 14 indexed citations

17.

Finlay, Judith A., John Day, & Harry G. Rittenhouse. (1999). Polyclonal and monoclonal antibodies to prostate-specific antigen can cross-react with human kallikrein 2 and human kallikrein 1. Urology. 53(4). 746–751. 11 indexed citations

18.

Lin, Daniel W., William J. Ellis, Paul H. Lange, et al.. (1999). SERUM HUMAN GLANDULAR KALLIKREIN (hK2) IN METASTATIC PROSTATE CANCER. The Journal of Urology. 96–96. 2 indexed citations

19.

Finlay, Judith A., Cindy L. Evans, John Day, et al.. (1998). Development of Monoclonal Antibodies Specific for Human Glandular Kallikrein (hK2): Development of a Dual Antibody Immunoassay for hK2 with Negligible Prostate-Specific Antigen Cross-reactivity. Urology. 51(5). 804–809. 51 indexed citations

20.

Day, John, et al.. (1991). ALTERNATIVE METHODS FOR VENTILATING LONG ROAD TUNNELS. 23(10). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact